PHYTOCHEMICAL SCREENING AND EVALUATION OF ANTIOXIDANT PROPERTIES OF SECONDARY METABOLITES IN AQUEOUS EXTRACTS OF FICUS THONNINGII BLUME TESTED ON WISTAR RATS

Journal Title: European Journal of Pharmaceutical and Medical Research - Year 2019, Vol 6, Issue 2

Abstract

Introduction: Traditional medicine methods have had a very long history to treat every sort of health disorder. The World Health Organization estimates that around 80 % of the world population in developing countries relies on traditional plant medicines for primary health care needs, of which a major proportion corresponds to plant extracts or their active principles. Plants and herbs have been used since ancient times to treat different gastrointestinal illnesses, including peptic ulcers. Objective: To identify the major classes of secondary metabolites and evaluate the antioxidant property of the aqueous extracts of Ficus thonningii. Methods: The phytochemical screening of the extracts was done using the Odebiyi and Sofowora method. Various biochemical parameters such as the Malondialdehyde (MDA), Catalase, Glutathione, Superoxide dismutase (SOD), Xanthine Oxidase (XO), were quantified using standard regulatory techniques. Results: The phytochemical screening of the extract of the F. thonningii stem bark showed the presence of the sapononins, quinones, coumarins, catechic tannins, phlobotanins, anthocyanins, flavonoids and betacyanes. The extract resulted in a non-significant increase of SOD, Catalase and glutathione in the preventive and curative activity. There was a dose-dependent significant decrease in MDA P<0.05. The MDA content was higher in the group receiving the extract 500 mg/Kg, omeprazole and healthy animals, but lower in the negative control group. Conclusion:The phytochemical screening of the extract of the bark showed the presence of the saponins, quinones, coumarins, catechic tannins, phlobotanins, anthocyanin, polyphenols, flavonoïds and betacyanes. The extract resulted in a non-significant increase of SOD, Catalase and glutathione with a dose dependent decrease in MDA. The administration of this extract with 2000 mg/Kg dose was well tolerated with no lethality observed.

Authors and Affiliations

Charles Ntungwen Fokunang

Keywords

Related Articles

INTEGRAL ASSESSMENT OF FACTORS AFFECTING THE EFFECTIVENESS OF ACCOMPANYING IMMUNOTHERAPY IN ONCOGYNECOLOGICAL PATIENTS

According to our data, the overall 5-year survival rates in patients with cervical cancer II-III stages after complex therapy in combination with immunotherapy were as follows: in the group of patients receiving EIPT wit...

CONTRIBUTION STUDY OF THE FIXED OIL IN LAURUS NOBILIS L. WIDE SPREAD IN SYRIA

The fixed oil was extracted from samples taken from two regions with different heights in Syria by using petroleum ether in ultrasonic bath. Gas Chromatography was used in order to determine the analytical different of t...

PLASMA LONG NON-CODING RNA SNHG-18 IS A VALUABLE MARKER FOR THE SCREENING OF NON-SMALL CELL LUNG CANCER

Many research studies have proven that long non-coding RNAs (lncRNAs) may play a critical role in various cancer development and progression. However, little is known the clinical aspect of small nucleolar RNA host gene...

THE APPENDICEAL MUCOCELE AN ENTITY NOT TO BE UNDERESTIMATE.

Appendiceal mucocele is a rare disease. Sometimes it is discovered accidentally and sometimes it resembles acute appendicitis. Correct diagnosis before surgery is important for the selection of adequate surgical treatmen...

A FOCUS ON FAILURE OF DRUG THERAPY FOR TARGETING CANCER STEM CELL: A REVIEW

Medical oncology and innovation in pharmaceutical industry, targeted therapy provides physicians and patients with more options to improve clinical outcomes as evidenced by improvement in overall survival (OS), progressi...

Download PDF file
  • EP ID EP672607
  • DOI -
  • Views 120
  • Downloads 0

How To Cite

Charles Ntungwen Fokunang (2019). PHYTOCHEMICAL SCREENING AND EVALUATION OF ANTIOXIDANT PROPERTIES OF SECONDARY METABOLITES IN AQUEOUS EXTRACTS OF FICUS THONNINGII BLUME TESTED ON WISTAR RATS. European Journal of Pharmaceutical and Medical Research, 6(2), 121-129. https://www.europub.co.uk/articles/-A-672607